Press release
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ: SVRA)

An investigation on behalf of current long term investors in Savara Inc. (NASDAQ: SVRA) shares over possible breaches of fiduciary
Investors who are current long term investors in Savara Inc. (NASDAQ: SVRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SVRA stocks follows a lawsuit filed against Savara Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: SVRA stocks, concerns whether certain Savara Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that the Defendants failed to disclose to investors that the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls, that accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form, that the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors, that the delay in MOLBREEVI's regulatory approval increased the likelihood that the Company would need to raise additional capital, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ: SVRA) here
News-ID: 4279182 • Views: …
More Releases from Shareholders Foundation, Inc.
Long-Term Investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) should contact the …
An investigation was announced for long-term investors in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) concerning potential breaches of fiduciary duties by certain directors and officers of Lantheus Holdings, Inc..
Investors who are current long term investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Skye Bioscience, Inc. (NASDAQ: SKYE) Investor NOTICE: Deadline in Lawsuit on Jan …
A deadline is coming up on January 16, 2026 in the lawsuit filed for certain investors of Skye Bioscience, Inc. (NASDAQ: SKYE) over alleged securities laws violations by Skye Bioscience, Inc.
Investors who purchased shares of Skye Bioscience, Inc. (NASDAQ: SKYE) have certain options and there are strict and short deadlines running. Deadline: January 16, 2026. Skye Bioscience, Inc. (NASDAQ: SKYE) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Investigation announced for Long-Term Investors in shares of V.F. Corporation (N …
An investigation was announced for long-term investors in shares of V.F. Corporation (NYSE: VFC) concerning potential breaches of fiduciary duties by certain directors of V.F. Corporation.
Investors who are current long term investors in V.F. Corporation (NYSE: VFC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: VFC stocks…
Perrigo Company plc (NYSE: PRGO) Investor Alert: Deadline in Lawsuit on January …
A deadline is coming up on January 16, 2026 in the lawsuit filed for certain investors of Perrigo Company plc (NYSE: PRGO) over alleged securities laws violations by Perrigo Company plc.
Investors who purchased shares of Perrigo Company plc (NYSE: PRGO) have certain options and there are strict and short deadlines running. Deadline: January 16, 2026. Perrigo Company plc (NYSE: PRGO) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
More Releases for Savara
Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 20 …
A deadline is coming up on November 7, 2025 in the lawsuit filed for certain investors of Savara Inc. (NASDAQ: SVRA) over alleged securities laws violations by Savara Inc.
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and there are strict and short deadlines running. Deadline: November 7, 2025. Savara Inc. (NASDAQ: SVRA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors who lost money with shares of Savara Inc. (NASDAQ: S …
An investor, who purchased shares of Savara Inc. (NASDAQ: SVRA), filed a lawsuit over alleged violations of Federal Securities Laws by Savara Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and for certain investors are short and strict deadlines running. Deadline: November 7, 2025. NASDAQ: SVRA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Autoimmune Pulmonary Alveolar Proteinosis Market to Expand Significantly by 2032 …
The Key Autoimmune Pulmonary Alveolar Proteinosis Companies in the market include - Savara Inc., and others.
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market to Observe Impressive Gr …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Autoimmune Pulmonary Alveolar Proteinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click…